Business Update10 Oct 2026, 03:29 pm
Shilpa Medicare Unit 4 Gets Europe GMP Approval
AI Summary
Shilpa Medicare Limited's Unit 4 in Jadcherla, Telangana, has received GMP Certification from AGES, Austria, following a successful inspection. This unit is crucial for manufacturing, testing, and distributing sterile injections and non-sterile tablets and capsules for European and global markets. The approval signifies adherence to stringent European quality standards, potentially boosting export capabilities and market access.
Key Highlights
- Shilpa Medicare's Telangana Unit 4 received Europe GMP approval.
- The approval was granted by AGES, Austria, after a successful inspection.
- The unit manufactures sterile injections and non-sterile dosage forms.
- This enhances the company's market access in Europe and globally.
Price Impact
More from SHILPAMED